RSV in Acute Respiratory Infection Surveillance Among Community-Dwelling Elderly Aged ≥50 Years in China (RAISE)

Fudan University

Status: Not yet enrolling

Conditions: Acute Respiratory Infections (ARIs)

Treatments: Diagnostic Test: NP swabs

Study type: Observational

Funder types: Other

Identifiers

NCT07075029

RAISE

Details and patient eligibility

About

This is a multicenter, prospective, observational, community-based study designed to evaluate the incidence of respiratory syncytial virus (RSV) infection among community-dwelling elderly individuals in China, as well as their cohabiting older adults and children, over a 24-month period. During the study, home visits will be conducted to collect nasopharyngeal (NP) swabs from all community residents aged ≥50 years who report symptoms of acute respiratory infection (ARI). Pathogen detection will be performed using both point-of-care testing (POCT) and centralized laboratory analysis.

Full description

The study will cover about 10 communities representing diverse geographical locations, economic conditions, and population densities.

Enrollment: 28,800 estimated patients

Sex: All

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• CRE-ARI group:

  1. Male or female adults aged ≥50 years (calculated based on date of birth and date of visit).

  2. Presence one of the following conditions of ARI case definition :

     • At least two respiratory symptoms/signs within 48 hours prior to self-reporting OR
     • At least one respiratory symptom/sign + one systemic symptom/sign within 48 hours prior to self-reporting

  3. Provision of written informed consent by the participant or their legal guardian, in accordance with local EC (Ethics Committee) requirements.

• CAI group:

  1. In the household, include at least one patient meeting the inclusion criteria (index case[s]) of CRE-ARI group.
  2. Male or female adults aged ≥50 years or children aged<5 years (calculated based on date of birth and date of visit).
  3. In the household, apart from the index case(s), there are two or more members who meet the criteria (2) AND are willing to participate, regardless of whether these household members exhibit ARI symptoms.
  4. Provision of written informed consent by the participant or their legal guardian, in accordance with local EC (Ethics Committee) requirements.

Exclusion criteria

1. Enrollment in the CRE-ARI group within the preceding 14 days.
2. Enrollment in the CRE-ARI group has been more than 4 times during the previous 12 months (applicable only to the CRE-ARI group enrollment).
3. For CAI group, if a household has been enrolled into CAI group within the previous 12 months.
4. Residence outside the designated study catchment area.
5. Unwilling to provide consent/assent (if applicable) to participate.
6. Unwilling to provide biological samples.
7. Any other situation deemed inappropriate for participation by the investigator, including potential risks to the subject upon enrollment or factors that may affect the interpretation of study results, such as clinical judgment, safety concerns, or the integrity of the study.

Trial design

28,800 participants in 2 patient groups

CRE-ARI group

Description:

CRE-ARI group will includes individuals aged 50 years and older who self-report symptoms of acute respiratory infection (ARI) to the investigators/study personnel during the study period.

Treatment:

Diagnostic Test: NP swabs

CAI group

Description:

Cohabitants of individuals with ARI will also be enrolled in the study, forming the Cohabitants of ARI Individuals (CAI) group. Eligible participants in this group include older adults aged ≥50 years and children under 5 years of age.

Treatment:

Diagnostic Test: NP swabs